Any treatment plan involving these agents should include: Regular blood tests (glucose, HbA1c, IGF-1, lipids, liver function, renal function) Documented informed consent regarding off-label or investigational use Dietitian input to monitor nutritional status, particularly during periods of rapid weight loss or reduced appetite Reconciliation of all concomitant medicines , including over-the-counter products and supplements, to minimise interaction risks Clear escalation pathways if side effects arise, including urgent review for severe abdominal pain, dehydration, or hypoglycaemia Ongoing review by a named responsible clinician Reporting of any suspected adverse effects via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk) Your health and safety are best protected by working transparently within the NHS or a regulated private medical setting, with full disclosure of all medicines prescribed or otherwise that you are taking

Boosted Libido (Via Vitality): Chronic fatigue and low energy are major contributors to low sex drive
InjectCos weight loss program includes ongoing support and progress tracking, with continued access to the care team between check-ins to help you stay engaged throughout the program
Additional drugs from other companies that have signed an MFN will be made available through the website in the coming months
If you eat in response to stress, boredom, or emotions, you might still experience strong urges to eat even when not physically hungry